These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2412191)

  • 1. Antinociceptive and neurotoxic actions of substance P analogues in the rat's spinal cord after intrathecal administration.
    Post C; Paulsson I
    Neurosci Lett; 1985 Jun; 57(2):159-64. PubMed ID: 2412191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do local vasomotor effects elicit the motor deficits induced by intrathecally applied substance P antagonists in the rat?
    Barber A; Wild A; Wedel R
    Neurosci Lett; 1987 Sep; 80(2):219-23. PubMed ID: 2446208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural and antinociceptive effects of intrathecally injected substance P analogues in mice.
    Post C; Folkers K
    Eur J Pharmacol; 1985 Jul; 113(3):335-43. PubMed ID: 2412846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal oxymetazoline does not produce neurotoxicity in the spinal cord of the rat.
    Loomis CW; Vyas D; Sherman SE
    Brain Res; 1992 Dec; 599(1):73-82. PubMed ID: 1283563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal somatostatin, somatostatin analogs, substance P analog and dynorphin A cause comparable neurotoxicity in rats.
    Gaumann DM; Grabow TS; Yaksh TL; Casey SJ; Rodriguez M
    Neuroscience; 1990; 39(3):761-74. PubMed ID: 1711172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species differences in the behavioral toxicity produced by intrathecal substance P antagonists: relationship to analgesia.
    Vaught JL; Scott R
    Life Sci; 1987 Jan; 40(2):175-81. PubMed ID: 2432377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the toxicity of subarachnoid clonidine, guanfacine, and a substance P-antagonist on rat spinal cord and nerve roots: light and electron microscopic observations after chronic intrathecal administration.
    Gordh T; Post C; Olsson Y
    Anesth Analg; 1986 Dec; 65(12):1303-11. PubMed ID: 2430489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoconstrictor effects in spinal cord of the substance P antagonist [D-Arg, D-Trp7,9 Leu11]-substance P (Spantide) and somatostatin and interaction with thyrotropin releasing hormone.
    Freedman J; Post C; Kåhrström J; Ohlen A; Mollenholt P; Owman C; Alari L; Hökfelt T
    Neuroscience; 1988 Oct; 27(1):267-78. PubMed ID: 2462190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal substance P analogue causes motor dysfunction in the rat.
    Matsumura H; Sakurada T; Hara A; Kuwahara H; Ando R; Sakurada S; Kisara K
    Neuropharmacology; 1985 Aug; 24(8):811-3. PubMed ID: 2427968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of substance P antagonists with serotonin in the mouse spinal cord.
    Vaught JL; Scott R
    Peptides; 1988; 9(4):909-13. PubMed ID: 2465543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of substance P analogues on spinal dorsal horn neurons.
    Randic M; Jeftinija S; Urban L; Raspantini C; Folkers K
    Peptides; 1988; 9(3):651-60. PubMed ID: 2458574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive effects in mice after intrathecal injection of a substance P receptor antagonist, Spantide: lack of 'neurotoxic' action.
    Post C; Freedman J; Paulsson I; Hökfelt T
    Regul Pept; 1987 Sep; 18(5-6):243-52. PubMed ID: 2445004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive and 'neurotoxic' actions of somatostatin in rat spinal cord after intrathecal administration.
    Mollenholt P; Post C; Rawal N; Freedman J; Hökfelt T; Paulsson I
    Pain; 1988 Jan; 32(1):95-105. PubMed ID: 2893326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance p analogue blocks sp-induced facilitation of a spinal nociceptive reflex.
    Yashpal K; Henry JL
    Brain Res Bull; 1984 Oct; 13(4):597-600. PubMed ID: 6084544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated intrathecal injections of dezocine produce antinociception without evidence for neurotoxicity in the rat: a study of morphometric evaluation of spinal cord histology.
    Svensson BA; Alari L; Post C
    Anesth Analg; 1992 Sep; 75(3):392-9. PubMed ID: 1510261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the hyperalgesic effect induced by intrathecal injection of substance P.
    Matsumura H; Sakurada T; Hara A; Sakurada S; Kisara K
    Neuropharmacology; 1985 May; 24(5):421-6. PubMed ID: 2410805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin-releasing hormone (TRH) counteracts neuronal damage induced by a substance P antagonist.
    Freedman J; Hökfelt T; Jonsson G; Post C
    Exp Brain Res; 1986; 62(1):175-8. PubMed ID: 2420632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The behavioural effects of intrathecally administered [D-PRO2, D-TRP7,9]-substance P, an analogue with presumed antagonist actions, in the rat.
    Rodriguez RE; Salt TE; Cahusac PM; Hill RG
    Neuropharmacology; 1983 Feb; 22(2):173-6. PubMed ID: 6188071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between serotonin and substance P in the spinal regulation of nociception.
    Eide PK; Hole K
    Brain Res; 1991 Jun; 550(2):225-30. PubMed ID: 1715803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P, injected intrathecally, antagonizes the spinal antinociceptive effect of morphine, baclofen and noradrenaline.
    Sawynok J; Moochhala SM; Pillay DJ
    Neuropharmacology; 1984 Jul; 23(7A):741-7. PubMed ID: 6206433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.